Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities:
Net income	$ 103,782	$ 111,270
Amounts to reconcile net income to net cash flows provided by operating activities:
Provision (benefit) for deferred income taxes	(500)	279
Depreciation and amortization	83,862	81,888
Amortization of deferred financing costs	3,958	3,647
Write-off of deferred financing costs	925
Stock-based compensation expense	4,954	4,594
Changes in:
Trade receivables	(8,865)	(3,220)
Accounts payable and accrued liabilities	31,994	2,647
Other assets and liabilities	(4,340)	(1,989)
Net cash flows provided by operating activities	215,770	199,116
Cash Flows from Investing Activities:
Purchases of property and equipment	(127,148)	(84,557)
Investment in Gaylord Rockies joint venture	(16,309)	(50,443)
Investment in other joint ventures	(6,819)	(750)
Proceeds from sale of Peterson LOI		6,785
(Increase) decrease in restricted cash and cash equivalents	7,359	(3,517)
Other investing activities	(4,139)	1,023
Net cash flows used in investing activities	(147,056)	(131,459)
Cash Flows from Financing Activities:
Net borrowings (repayments) under revolving credit facility	(235,900)	60,500
Borrowings under term loan A	200,000
Borrowings under term loan B	500,000
Repayments under term loan B	(392,500)	(3,000)
Deferred financing costs paid	(12,268)
Repayment of note payable related to purchase of AC Hotel		(6,000)
Repurchase of Company stock for retirement		(24,811)
Payment of dividends	(120,740)	(112,900)
Payment of tax withholdings for share-based compensation	(3,775)	(3,150)
Other financing activities	13	1,271
Net cash flows used in financing activities	(65,170)	(88,090)
Net change in cash and cash equivalents	3,544	(20,433)
Cash and cash equivalents - unrestricted, beginning of period	59,128	56,291
Cash and cash equivalents - unrestricted, end of period	$ 62,672	$ 35,858